Alkem Laboratories shares fall 2.02% in Wednesday's trading session

Shares of Alkem Laboratories declined by 2.02% to trade at Rs 4,821.50 in Wednesday's session. The stock is a constituent of the Nifty Midcap 150 index.

In related corporate actions, the company has scheduled a conference call on August 12, 2025, at 4:30 p.m. to discuss the Q1 FY26 financial results. Additionally, a board meeting is scheduled for August 12, 2025, to consider and approve the standalone and consolidated unaudited financial results for the quarter ending June 30, 2025.

Recent Financial Performance:

Alkem Laboratories' recent financial performance shows the following trends based on consolidated quarterly data:

• Revenue: The company's revenue has fluctuated over the past five quarters, with a recent figure of Rs 3,143.75 Crore for the quarter-ending March 2025.


• Net Profit: Net profit also varied, with Rs 323.01 Crore reported for the quarter-ending March 2025.


• EPS: Earnings per share stood at Rs 25.57 for the quarter-ending March 2025.

Annual Consolidated Financials:

The yearly financial performance provides the following insights:

• Revenue: There has been a steady increase in revenue over the years, with Rs 12,964.52 Crore reported for the year-ending March 2025.


• Net Profit: Net profit has also increased, reaching Rs 2,216.00 Crore for the year-ending March 2025.


• EPS: The Earnings Per Share (EPS) has risen to Rs 181.11 for the year-ending March 2025.

The revenue for the year ending March 2025 increased by 2.34% compared to the year ending March 2024. Net profit for the year ending March 2025 also increased by 22.33% compared to the previous year.

Alkem Laboratories announced a final dividend of Rs 8 per share (400%) with an effective date of August 8, 2025. Prior to this, an interim dividend of Rs 37 per share (1850%) was announced on January 28, 2025, with an effective date of February 14, 2025.